IDEX beats Q1 estimates, maintains full-year guidance amid economic uncertainty

Published 01/05/2025, 12:22
IDEX beats Q1 estimates, maintains full-year guidance amid economic uncertainty

NORTHBROOK, Ill. - IDEX Corporation (NYSE:IEX) reported first-quarter 2025 results that surpassed analyst expectations, with adjusted earnings per share of $1.75 beating estimates by $0.08 and revenue of $872 million exceeding the consensus of $810.42 million. The company maintained its full-year organic sales growth and earnings per share guidance ranges despite potential economic headwinds.

IDEX’s first-quarter sales increased 2% YoY but decreased 1% organically. The company reported record orders of $872 million, up 6% overall and 1% organically, marking the fourth consecutive quarter of positive organic order growth. Notably, both the Health & Science Technologies (HST) and Fire & Safety/Diversified Products (FSDP) segments achieved record orders.

Eric Ashleman, IDEX Corporation President and CEO, commented, "Our IDEX teams delivered better than expected revenue and profitability in the first quarter of 2025, with all segments exceeding our expectations. Most encouragingly, all of our segments built backlog, mostly accumulating within HST, fueled by an impressive large clean water project win from the Mott team."

For the second quarter of 2025, IDEX projects earnings per share between $1.95 and $2.05, slightly below the analyst consensus of $2.10. The company’s full-year 2025 EPS guidance of $8.10 to $8.45 aligns with the consensus estimate of $8.11.

Addressing potential economic challenges, IDEX announced an additional $20 million in cost containment actions for 2025 to offset possible tariff-related volume pressure. These measures come on top of the company’s ongoing platform optimization and delayering efforts, which are expected to yield $43 million in impact for 2025.

Ashleman emphasized IDEX’s strong position amid economic uncertainty, citing the company’s critical solutions, long-standing customer relationships, and ability to quickly shift resources to advantaged applications. He also highlighted IDEX’s robust cash generation and balance sheet, which provide flexibility for capital deployment and potential M&A activities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.